Profilin-1 versus profilin-2: Two faces of the same coin?

Breast Cancer Research

Volumn 15, Issue 3, 2013, Pages

  Ding, Zhijie ^a   Roy, Partha ^a,b,c,d  

^a University of Pittsburgh   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; PROFILIN; PROFILIN I; PROFILIN II; UNCLASSIFIED DRUG; PROTEIN BINDING;

ACTIN POLYMERIZATION; ARTICLE; BREAST CANCER; CANCER CELL; CELL MIGRATION; CELL MOTILITY; CYTOSKELETON; DOWN REGULATION; HUMAN; PROTEIN FAMILY; PROTEIN INTERACTION; TUMOR INVASION; ACTIN FILAMENT; BREAST TUMOR; CELL MOTION; FEMALE; GENETICS; METABOLISM; PATHOLOGY;

ACTIN CYTOSKELETON; BREAST NEOPLASMS; CELL MOVEMENT; FEMALE; HUMANS; PROFILINS; PROTEIN BINDING;

EID: 84879839141     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr3433     Document Type: Article

References (12)

1. Ding Z, Bae YH, Roy P. Molecular insights on context-specific role of profilin-1 in cell migration. Cell Adh Migr 2012, 6:442-449. 10.4161/cam.21832, 23076048.
2. Witke W. The role of profilin complexes in cell motility and other cellular processes. Trends Cell Biol 2004, 14:461-469. 10.1016/j.tcb.2004.07.003, 15308213.
3. Lambrechts A, Braun A, Jonckheere V, Aszodi A, Lanier LM, Robbens J, Colen IV, Vandekerckhove J, Fassler R, Ampe C. Profilin II is alternatively spliced, resulting in profilin isoforms that are differently expressed and have distinct biochemical properties. Mol Cell Biol 2000, 20:8209-8219. 10.1128/MCB.20.21.8209-8219.2000, 86430, 11027290.
4. Michaelsen K, Murk K, Zagrebelsky M, Dreznjak A, Jockusch BM, Rothkegel M, Korte M. Fine-tuning of neuronal architecture requires two profilin isoforms. Proc Natl Acad Sci USA 2010, 107:15780-15785. 10.1073/pnas.1004406107, 2936622, 20798032.
5. Mouneimne G, Hansen SD, Selfors LM, Petrak L, Hickey MM, Gallegos LL, Simpson KJ, Lim J, Gertler FB, Hartwig JH, Mullins RD, Brugge JS. Differential remodeling of actin cytoskeleton architecture by profilin isoforms leads to distinct effects on cell migration and invasion. Cancer Cell 2012, 22:615-630. 10.1016/j.ccr.2012.09.027, 23153535.
6. Janke J, Schlüter K, Jandrig B, Theile M, Kölble K, Arnold W, Grinstein E, Schwartz A, Estevéz-Schwarz L, Schlag PM, Jockusch BM, Scherneck S. Suppression of tumorigeniciy in breast cancer cells by the microfilament protein profilin 1. J Exp Med 2000, 191:1675-1685. 10.1084/jem.191.10.1675, 2193149, 10811861.
7. Zoidakis J, Makridakis M, Zerefos PG, Bitsika V, Esteban S, Frantzi M, Stravodimos K, Anagnou NP, Roubelakis MG, Sanchez-Carbayo M, Vlahou A. Profilin 1 is a potential biomarker for bladder cancer aggressiveness. Mol Cell Proteomics 2012, 11:M111 009449. 3322560, 22159600.
8. Ding Z, Joy M, Bhargava R, Gunsaulus M, Lakshman N, Miron-Mendoza M, Petroll M, Condeelis J, Wells A, Roy P. Profilin-1 downregulation has contrasting effects on early vs late steps of breast cancer metastasis. Oncogene 2013, doi:10.1038/onc.2013.166.
9. Bae YH, Ding Z, Zou L, Wells A, Gertler F, Roy P. Loss of profilin-1 expression enhances breast cancer cell motility by Ena/VASP proteins. J Cell Physiol 2009, 219:354-364. 10.1002/jcp.21677, 2990882, 19115233.
10. Zou L, Jaramillo M, Whaley D, Wells A, Panchapakesa V, Das T, Roy P. Profilin-1 is a negative regulator of mammary carcinoma aggressiveness. Br J Cancer 2007, 97:1361-1371. 10.1038/sj.bjc.6604038, 2360229, 17940506.
11. Fan Y, Arif A, Gong Y, Jia J, Eswarappa SM, Willard B, Horowitz A, Graham LM, Penn MS, Fox PL. Stimulus-dependent phosphorylation of profilin-1 in angiogenesis. Nat Cell Biol 2012, 14:1046-1056. 10.1038/ncb2580, 23000962.
12. Bae YH, Ding Z, Das T, Wells A, Gertler F, Roy P. Profilin1 regulates PI(3,4)P2 and lamellipodin accumulation at the leading edge thus influencing motility of MDA-MB-231 cells. Proc Natl Acad Sci USA 2010, 107:21547-21552. 10.1073/pnas.1002309107, 3003040, 21115820.